ATE228132T1 - Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung - Google Patents

Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung

Info

Publication number
ATE228132T1
ATE228132T1 AT94908108T AT94908108T ATE228132T1 AT E228132 T1 ATE228132 T1 AT E228132T1 AT 94908108 T AT94908108 T AT 94908108T AT 94908108 T AT94908108 T AT 94908108T AT E228132 T1 ATE228132 T1 AT E228132T1
Authority
AT
Austria
Prior art keywords
trifluoromethylpyrroloindole
production
carboxylic acid
ester derivative
arylsulfonyloxy
Prior art date
Application number
AT94908108T
Other languages
English (en)
Inventor
Shiro Terashima
Yasumichi Fukuda
Yasuo Oomori
Original Assignee
Kyorin Seiyaku Kk
Sagami Chem Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk, Sagami Chem Res filed Critical Kyorin Seiyaku Kk
Application granted granted Critical
Publication of ATE228132T1 publication Critical patent/ATE228132T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Laminated Bodies (AREA)
AT94908108T 1992-08-21 1993-08-19 Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung ATE228132T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22286292 1992-08-21
JP20425593A JP3514490B2 (ja) 1992-08-21 1993-08-18 トリフルオロメチルピロロインドールカルボン酸エステル誘導体及びその製造方法
PCT/JP1993/001159 WO1994004535A1 (fr) 1992-08-21 1993-08-19 Derive d'ester carboxylique de trifluoromethylpyrroloindole et procede pour sa fabrication

Publications (1)

Publication Number Publication Date
ATE228132T1 true ATE228132T1 (de) 2002-12-15

Family

ID=26514369

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94908108T ATE228132T1 (de) 1992-08-21 1993-08-19 Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung

Country Status (13)

Country Link
US (1) US5629430A (de)
EP (1) EP0656360B1 (de)
JP (1) JP3514490B2 (de)
KR (2) KR100312444B1 (de)
AT (1) ATE228132T1 (de)
CA (1) CA2142869C (de)
DE (1) DE69332504T2 (de)
DK (1) DK0656360T3 (de)
ES (1) ES2188608T3 (de)
HU (1) HU221041B1 (de)
PT (1) PT656360E (de)
TW (1) TW394774B (de)
WO (1) WO1994004535A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100395083B1 (ko) * 1994-11-29 2004-02-05 자이단호오징 사가미 츄오 카가쿠겡큐쇼 아크릴아미드유도체및그제조방법
AU3463197A (en) * 1996-07-23 1998-02-10 Kyowa Hakko Kogyo Co. Ltd. Dc-89 derivatives
AU5576098A (en) * 1997-01-24 1998-08-18 Kyorin Pharmaceutical Co. Ltd. Pyrroloindole derivatives and intermediates in producing the same
US6310209B1 (en) 1997-12-08 2001-10-30 The Scripps Research Institute Synthesis of CC-1065/duocarmycin analogs
US7087600B2 (en) * 2001-05-31 2006-08-08 Medarex, Inc. Peptidyl prodrugs and linkers and stabilizers useful therefor
JP2006505571A (ja) * 2002-10-15 2006-02-16 リゲル ファーマシューテイカルズ、インコーポレイテッド 置換されたインドール及びｈｃｖ阻害剤としてのその使用
GB0403038D0 (en) 2004-02-11 2004-03-17 Novartis Ag Organic compounds
US7517903B2 (en) * 2004-05-19 2009-04-14 Medarex, Inc. Cytotoxic compounds and conjugates
US7691962B2 (en) * 2004-05-19 2010-04-06 Medarex, Inc. Chemical linkers and conjugates thereof
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
MX2007009878A (es) * 2005-02-18 2007-10-03 Medarex Inc Anticuerpos monoclonales para antigeno de membrana especifica para prostata (amep).
US7714016B2 (en) * 2005-04-08 2010-05-11 Medarex, Inc. Cytotoxic compounds and conjugates with cleavable substrates
AU2006294554B2 (en) * 2005-09-26 2013-03-21 E. R. Squibb & Sons, L.L.C. Antibody-drug conjugates and methods of use
CN101365679B (zh) 2005-10-26 2012-11-14 梅达莱克斯公司 制备cc-1065类似物的方法和化合物
CA2627190A1 (en) 2005-11-10 2007-05-24 Medarex, Inc. Duocarmycin derivatives as novel cytotoxic compounds and conjugates
TWI412367B (zh) 2006-12-28 2013-10-21 梅達雷克斯有限責任公司 化學鏈接劑與可裂解基質以及其之綴合物
KR20090122439A (ko) 2007-02-21 2009-11-30 메다렉스, 인코포레이티드 단일 아미노산을 갖는 화학적 링커 및 이의 접합체
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
WO2009067489A1 (en) * 2007-11-20 2009-05-28 Lankenau Institute For Medical Research Disulfide chemotherapeutic agents and methods of use thereof
MX2011004625A (es) * 2008-11-03 2011-07-20 Syntarga Bv Analogos cc-1065 novedosos y sus conjugados.
US8697391B2 (en) 2009-05-15 2014-04-15 Lankenau Institute For Medical Research Method of determining cell number or viability using hydroxyethyldisulfide
CA2956934C (en) 2010-04-21 2019-07-09 Syntarga B.V. Novel conjugates of cc-1065 analogs and bifunctional linkers
AU2012395148B2 (en) 2012-11-24 2016-10-27 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
AU2015205574B2 (en) 2014-01-10 2019-08-15 Byondis B.V. Method for purifying Cys-linked antibody-drug conjugates
MX368396B (es) 2014-01-10 2019-10-01 Synthon Biopharmaceuticals Bv Conjugados de anticuerpo-farmaco (adc) de duocarmicina que muestran actividad antitumoral in vivo mejorada.
HRP20160797T1 (hr) 2014-01-10 2016-08-12 Synthon Biopharmaceuticals B.V. Duokarmicin adsc, namijenjen upotrebi u liječenju raka endometrija
FI3122757T3 (fi) 2014-02-28 2023-10-10 Hangzhou Dac Biotech Co Ltd Varautuneita linkkereitä ja niiden konjugointikäyttötapoja
EP3319936B1 (de) 2015-07-12 2025-12-17 Hangzhou Dac Biotech Co., Ltd. Brückenlinker zur konjugation von zellbindenden molekülen
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
AU2016429272A1 (en) 2016-11-14 2019-05-02 Hangzhou Dac Biotech Co., Ltd. Conjugation linkers, cell binding molecule-drug conjugates containing the likers, methods of making and uses such conjugates with the linkers
WO2022055926A1 (en) * 2020-09-11 2022-03-17 The Regents Of The University Of California Compositions and methods for treating muscular dystrophies
CN112724068A (zh) * 2020-12-30 2021-04-30 蔡桂坡 具有hdac抑制活性的吲哚类衍生物的合成方法及肿瘤应用
CN117980327A (zh) 2021-11-03 2024-05-03 杭州多禧生物科技有限公司 抗体的特异性偶联

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978757A (en) * 1984-02-21 1990-12-18 The Upjohn Company 1,2,8,8a-tetrahydrocyclopropa (C) pyrrolo [3,2-e)]-indol-4(5H)-ones and related compounds
JP2598116B2 (ja) * 1988-12-28 1997-04-09 協和醗酵工業株式会社 新規物質ｄｃ１１３
JP2510335B2 (ja) * 1989-07-03 1996-06-26 協和醗酵工業株式会社 Ｄｃ―８８ａ誘導体
JP3037965B2 (ja) * 1990-06-20 2000-05-08 財団法人相模中央化学研究所 ２―アルコキシカルボニル―２―メチル―１―オキソ―１，２，３，６，７，８―ヘキサヒドロ―ベンゾ〔１，２―ｂ；４，３―ｂ´〕ジピロール誘導体
JPH0499774A (ja) * 1990-08-14 1992-03-31 Sagami Chem Res Center ２―エピデュオカルマイシンａおよびその製造中間体

Also Published As

Publication number Publication date
DK0656360T3 (da) 2003-03-17
US5629430A (en) 1997-05-13
JPH06116269A (ja) 1994-04-26
DE69332504D1 (de) 2003-01-02
EP0656360A1 (de) 1995-06-07
CA2142869C (en) 2002-01-01
ES2188608T3 (es) 2003-07-01
EP0656360A4 (de) 1995-08-30
KR100312445B1 (ko) 2001-11-09
AU689443B2 (en) 1998-04-02
AU4761893A (en) 1994-03-15
DE69332504T2 (de) 2003-10-02
EP0656360B1 (de) 2002-11-20
TW394774B (en) 2000-06-21
HU221041B1 (hu) 2002-07-29
HU9500494D0 (en) 1995-04-28
JP3514490B2 (ja) 2004-03-31
WO1994004535A1 (fr) 1994-03-03
HUT71493A (en) 1995-11-28
PT656360E (pt) 2003-02-28
CA2142869A1 (en) 1994-03-03
KR100312444B1 (ko) 2002-02-28

Similar Documents

Publication Publication Date Title
DE69332504D1 (de) Trifluoromethylpyrroloindolcarbonsäure und dessen esterderivat sowie ein verfahren zu seiner herstellung
ATE271557T1 (de) Dc-89 derivat
ATE229527T1 (de) Pyrazolopyridylpyrazinon-derivate und ein verfahren zu ihrer herstellung
ATE165601T1 (de) Benzopyran-verbindungen, verfahren zu ihrer herstellung und ihre verwendung als zellenschutzmittel
ATE239732T1 (de) Indol-derivat, verfahren zu dessen herstellung und dessen medizinische anwendung
NO913087L (no) Ny tricyklisk forbindelse eller salter derav, fremgangsmaate for fremstilling derav og antimikrobielt middel inneholdende slike.
DE3576955D1 (de) Beta-carbolin-3-oxadiazolylderivate, verfahren zu ihrer herstellung und ihre verwendung.
DK0916651T3 (da) Phenylalkylcarboxylsyrederivater
NO20014119D0 (no) Medikament inneholdende et sulfopyranosylacylglycerolderivat
DE3578178D1 (de) Beta-carbolin-3-carbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung.
ATE100097T1 (de) Benzoxepin-derivate.
ATE194611T1 (de) Optisch aktive imidazolidinon-derivate und verfahren zu deren herstellung
AU7624494A (en) Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia
ES2111086T3 (es) Compuestos triciclicos anfoteros como agentes antihistaminicos y antialergicos.
ATE189887T1 (de) Vitamin-d-derivat und verfahren zu seiner herstellung
EP0657443A4 (de) Optisch aktive carboxamidderivate.
DK0654473T3 (da) Cyclopropanderivater og antivirale midler med indhold deraf
DE69500198D1 (de) Zns mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen
DK0566288T3 (da) Flavon-derivater
ATE143957T1 (de) Aminoalkylchomone, verfahren für ihre herstellung und die enthaltende pharmazeutische zusammensetzungen
DE3884518D1 (de) Naphthothiazepin-derivate und verfahren zu ihrer herstellung.
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
NO175255C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive alkylestere av 2-(4-(2-piperidino-etoksy)-benzoyl)-benzosyre med forgrenet kjede
ATE170188T1 (de) 2'-desoxy-5-fluoruridin, pharmazeutisch anwendbare salze davon, verfahren zu ihrer herstellung und antitumormedikament
CA2122705A1 (en) Optically Active 1-Phenylpyrrolidone Derivative, Intermediate for Producing the Same, and Process for Producing Both

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0656360

Country of ref document: EP

REN Ceased due to non-payment of the annual fee